Arthur M - Search Results

1

Developing strategies for liver fibrosis treatment.

Murphy F, Arthur M, Iredale J. Murphy F, et al. Among authors: arthur m. Expert Opin Investig Drugs. 2002 Nov;11(11):1575-85. doi: 10.1517/13543784.11.11.1575. Expert Opin Investig Drugs. 2002. PMID: 12437504 Review.

2

Inhibition of apoptosis of activated hepatic stellate cells by tissue inhibitor of metalloproteinase-1 is mediated via effects on matrix metalloproteinase inhibition: implications for reversibility of liver fibrosis.

Murphy FR, Issa R, Zhou X, Ratnarajah S, Nagase H, Arthur MJ, Benyon C, Iredale JP. Murphy FR, et al. J Biol Chem. 2002 Mar 29;277(13):11069-76. doi: 10.1074/jbc.M111490200. Epub 2002 Jan 16. J Biol Chem. 2002. PMID: 11796725 Free article.

3

Hepatic lipocytes, TIMP-1 and liver fibrosis.

Arthur MJ, Iredale JP. Arthur MJ, et al. J R Coll Physicians Lond. 1994 May-Jun;28(3):200-8. J R Coll Physicians Lond. 1994. PMID: 7932316 Free PMC article. Review.

4

Tissue inhibitors of metalloproteinases: role in liver fibrosis and alcoholic liver disease.

Arthur MJ, Iredale JP, Mann DA. Arthur MJ, et al. Alcohol Clin Exp Res. 1999 May;23(5):940-3. doi: 10.1111/j.1530-0277.1999.tb04208.x. Alcohol Clin Exp Res. 1999. PMID: 10371419 Review.

5

N-Cadherin cleavage during activated hepatic stellate cell apoptosis is inhibited by tissue inhibitor of metalloproteinase-1.

Murphy F, Waung J, Collins J, Arthur MJ, Nagase H, Mann D, Benyon RC, Iredale JP. Murphy F, et al. Comp Hepatol. 2004 Jan 14;3 Suppl 1(Suppl 1):S8. doi: 10.1186/1476-5926-2-S1-S8. Comp Hepatol. 2004. PMID: 14960160 Free PMC article.

6

Spontaneous recovery from micronodular cirrhosis: evidence for incomplete resolution associated with matrix cross-linking.

Issa R, Zhou X, Constandinou CM, Fallowfield J, Millward-Sadler H, Gaca MD, Sands E, Suliman I, Trim N, Knorr A, Arthur MJ, Benyon RC, Iredale JP. Issa R, et al. Among authors: arthur mj. Gastroenterology. 2004 Jun;126(7):1795-808. doi: 10.1053/j.gastro.2004.03.009. Gastroenterology. 2004. PMID: 15188175

7

Expression of matrix metalloproteinase-2 and -14 persists during early resolution of experimental liver fibrosis and might contribute to fibrolysis.

Zhou X, Hovell CJ, Pawley S, Hutchings MI, Arthur MJ, Iredale JP, Benyon RC. Zhou X, et al. Liver Int. 2004 Oct;24(5):492-501. doi: 10.1111/j.1478-3231.2004.0946.x. Liver Int. 2004. PMID: 15482348

8

Tissue inhibitors of metalloproteinases, hepatic stellate cells and liver fibrosis.

Arthur MJ, Mann DA, Iredale JP. Arthur MJ, et al. J Gastroenterol Hepatol. 1998 Sep;13(S1):S33-S38. doi: 10.1111/jgh.1998.13.s1.33. J Gastroenterol Hepatol. 1998. PMID: 28976699

9

Human hepatic lipocytes synthesize tissue inhibitor of metalloproteinases-1. Implications for regulation of matrix degradation in liver.

Iredale JP, Murphy G, Hembry RM, Friedman SL, Arthur MJ. Iredale JP, et al. Among authors: arthur mj. J Clin Invest. 1992 Jul;90(1):282-7. doi: 10.1172/JCI115850. J Clin Invest. 1992. PMID: 1634616 Free PMC article.

10

Expression of tissue inhibitor of metalloproteinases 1 and 2 is increased in fibrotic human liver.

Benyon RC, Iredale JP, Goddard S, Winwood PJ, Arthur MJ. Benyon RC, et al. Among authors: arthur mj. Gastroenterology. 1996 Mar;110(3):821-31. doi: 10.1053/gast.1996.v110.pm8608892. Gastroenterology. 1996. PMID: 8608892

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

485 results

Search Page